These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25134723)

  • 1. The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.
    Pastukhov O; Schwalm S; Zangemeister-Wittke U; Fabbro D; Bornancin F; Japtok L; Kleuser B; Pfeilschifter J; Huwiler A
    Br J Pharmacol; 2014 Dec; 171(24):5829-44. PubMed ID: 25134723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CERK inhibition might be a good potential therapeutic target for diseases.
    Yu WL; Sun Y
    Br J Pharmacol; 2015 Apr; 172(8):2165. PubMed ID: 25411058
    [No Abstract]   [Full Text] [Related]  

  • 3. CERK might contribute to inflammatory pain; Comments on Yu WL, Sun. Y (2015). CERK inhibition might be a good potential therapeutic target for diseases. Br J Pharmacol 172: 2165.
    Huang JL; Huo Y; Wan LL; Yang QJ; Li J; Guo C
    Br J Pharmacol; 2016 Apr; 173(7):1248-9. PubMed ID: 26989987
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceramide kinase contributes to proliferation but not to prostaglandin E2 formation in renal mesangial cells and fibroblasts.
    Pastukhov O; Schwalm S; Römer I; Zangemeister-Wittke U; Pfeilschifter J; Huwiler A
    Cell Physiol Biochem; 2014; 34(1):119-33. PubMed ID: 24977486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide Kinase Is Upregulated in Metastatic Breast Cancer Cells and Contributes to Migration and Invasion by Activation of PI 3-Kinase and Akt.
    Schwalm S; Erhardt M; Römer I; Pfeilschifter J; Zangemeister-Wittke U; Huwiler A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro.
    Niwa S; Graf C; Bornancin F
    Microvasc Res; 2009 May; 77(3):389-93. PubMed ID: 19323974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A secondary assay for ceramide kinase inhibitors based on cell growth inhibition by short-chain ceramides.
    Graf C; Rovina P; Bornancin F
    Anal Biochem; 2009 Jan; 384(1):166-9. PubMed ID: 18831956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
    Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway.
    Shendge AK; Chaudhuri D; Basu T; Mandal N
    Clin Transl Oncol; 2021 Apr; 23(4):718-730. PubMed ID: 32715386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells.
    Zang QQ; Zhang L; Gao N; Huang C
    J Integr Med; 2016 Jan; 14(1):51-9. PubMed ID: 26778229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
    Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage.
    Huwiler A; Kotelevets N; Xin C; Pastukhov O; Pfeilschifter J; Zangemeister-Wittke U
    Br J Pharmacol; 2011 Jan; 162(2):532-43. PubMed ID: 20883472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
    Bini F; Frati A; Garcia-Gil M; Battistini C; Granado M; Martinesi M; Mainardi M; Vannini E; Luzzati F; Caleo M; Peretto P; Gomez-Muñoz A; Meacci E
    Neuropharmacology; 2012 Sep; 63(4):524-37. PubMed ID: 22579669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.
    Hu Y; Dragowska WH; Wallis A; Duronio V; Mayer L
    Breast Cancer Res Treat; 2001 Nov; 70(1):11-20. PubMed ID: 11767000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor.
    Graf C; Klumpp M; Habig M; Rovina P; Billich A; Baumruker T; Oberhauser B; Bornancin F
    Mol Pharmacol; 2008 Oct; 74(4):925-32. PubMed ID: 18612076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis.
    Kotelevets N; Fabbro D; Huwiler A; Zangemeister-Wittke U
    PLoS One; 2012; 7(6):e39209. PubMed ID: 22761740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.
    Tsai SC; Huang WW; Huang WC; Lu CC; Chiang JH; Peng SF; Chung JG; Lin YH; Hsu YM; Amagaya S; Yang JS
    Int J Oncol; 2012 Dec; 41(6):2065-72. PubMed ID: 23008020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest.
    Guan X; Guan Y
    J BUON; 2020; 25(3):1330-1336. PubMed ID: 32862573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3-dependent steps of apoptosis and the critical lethal lesions.
    Xue LY; Chiu SM; Oleinick NL
    Exp Cell Res; 2003 Feb; 283(2):135-45. PubMed ID: 12581734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.